CDH1 and meningioma: The down-regulation miR-21, combined with the overexpression of miR-34a, miR218, PTEN and E-cadherin (CDH1) could explain the benign nature of meningiomas (grades I and II) and represent barriers for grades I and II tumors from malignant progression.